Literature DB >> 18445355

Behavioral aspects of weight loss in type 2 diabetes.

Rena R Wing1, Becky Marquez.   

Abstract

Recent research has clearly shown that lifestyle intervention can reduce the risk of diabetes in those with impaired glucose tolerance; weight reduction appears to be the primary determinant of this effect. Weight loss can also improve glycemic control and cardiovascular risk factors in those with diabetes; however, the long-term impact of weight loss on cardiovascular morbidity and mortality is still under investigation. An important finding is that modest weight losses of just 5% to 10% of initial body weight appear sufficient to produce these benefits for diabetes prevention and cardiovascular risk reduction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445355     DOI: 10.1007/s11892-008-0023-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  20 in total

1.  Intentional weight loss and mortality among overweight individuals with diabetes.

Authors:  D F Williamson; T J Thompson; M Thun; D Flanders; E Pamuk; T Byers
Journal:  Diabetes Care       Date:  2000-10       Impact factor: 19.112

2.  Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model.

Authors:  Ronald T Ackermann; David G Marrero
Journal:  Diabetes Educ       Date:  2007 Jan-Feb       Impact factor: 2.140

Review 3.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

4.  Motivational interviewing improves weight loss in women with type 2 diabetes.

Authors:  Delia Smith West; Vicki DiLillo; Zoran Bursac; Stacy A Gore; Paul G Greene
Journal:  Diabetes Care       Date:  2007-03-02       Impact factor: 19.112

5.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

6.  An adaptation of the diabetes prevention program for use with high-risk, minority patients with type 2 diabetes.

Authors:  J Steven Cramer; Ralph F Sibley; Donald P Bartlett; Linda S Kahn; Lisa Loffredo
Journal:  Diabetes Educ       Date:  2007 May-Jun       Impact factor: 2.140

7.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10

8.  Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.

Authors:  Xavier Pi-Sunyer; George Blackburn; Frederick L Brancati; George A Bray; Renee Bright; Jeanne M Clark; Jeffrey M Curtis; Mark A Espeland; John P Foreyt; Kathryn Graves; Steven M Haffner; Barbara Harrison; James O Hill; Edward S Horton; John Jakicic; Robert W Jeffery; Karen C Johnson; Steven Kahn; David E Kelley; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Brenda Montgomery; David M Nathan; Jennifer Patricio; Anne Peters; J Bruce Redmon; Rebecca S Reeves; Donna H Ryan; Monika Safford; Brent Van Dorsten; Thomas A Wadden; Lynne Wagenknecht; Jacqueline Wesche-Thobaben; Rena R Wing; Susan Z Yanovski
Journal:  Diabetes Care       Date:  2007-03-15       Impact factor: 19.112

9.  Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial.

Authors:  Pilvikki Absetz; Raisa Valve; Brian Oldenburg; Heikki Heinonen; Aulikki Nissinen; Mikael Fogelholm; Vesa Ilvesmäki; Martti Talja; Antti Uutela
Journal:  Diabetes Care       Date:  2007-06-22       Impact factor: 19.112

10.  The U-shaped association between body mass index and mortality: relationship with weight gain in a Native American population.

Authors:  R L Hanson; D R McCance; L T Jacobsson; K M Narayan; R G Nelson; D J Pettitt; P H Bennett; W C Knowler
Journal:  J Clin Epidemiol       Date:  1995-07       Impact factor: 6.437

View more
  4 in total

Review 1.  Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysis.

Authors:  Feng Sun; Shanshan Wu; Shuxia Guo; Kai Yu; Zhirong Yang; Lishi Li; Yuan Zhang; Linong Ji; Siyan Zhan
Journal:  Endocrine       Date:  2014-08-13       Impact factor: 3.633

Review 2.  Management of the metabolic syndrome and type 2 diabetes through lifestyle modification.

Authors:  Faidon Magkos; Mary Yannakoulia; Jean L Chan; Christos S Mantzoros
Journal:  Annu Rev Nutr       Date:  2009       Impact factor: 11.848

Review 3.  Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors.

Authors:  L Romayne Kurukulasuriya; James R Sowers
Journal:  Cardiovasc Diabetol       Date:  2010-08-30       Impact factor: 9.951

4.  Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.

Authors:  Mário Raimundo; José António Lopes
Journal:  Cardiol Res Pract       Date:  2011-02-20       Impact factor: 1.866

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.